Editas Medicine, Inc.
CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING

Abstract:

The present disclosure relates to CRISPR/Cpf1-related methods and components for editing a target nucleic acid sequence and/or modulating expression of a target nucleic acid sequence, as well as methods and compositions for evaluating such editing and/or modulation of expression.